Son Dakika
BREUA atacam 90 alvos militares do Irã em nova rodada de bombardeiosRUМассовая гибель рыбы произошла в Ленинградской областиCN巴威颱風來襲,台中YouBike晚間10點後暫停營運ARالأنظار تتجه نحو مواجهة المغرب وفرنسا في ربع نهائي كأس العالمJPトランプ大統領、NATO会議を「大成功」と評価、態度一転に周囲驚くARنتنياهو: لن نسمح لإيران بامتلاك أسلحة نووية وسنبقى في جنوب لبنان طالما لزم الأمرDEDAX stabilisiert sich nach Verlusten; Iran-Konflikt und VW-Sparpläne belastenARالبنك المركزي المصري يثبت أسعار الفائدة الرئيسيةCRYPTO-ENSWIFT Pilot Allows Tokenized Deposits Over WeekendsDESachsens Kultusminister Conrad Clemens wegen illegalen Rennens schuldig gesprochenBREUA atacam 90 alvos militares do Irã em nova rodada de bombardeiosRUМассовая гибель рыбы произошла в Ленинградской областиCN巴威颱風來襲,台中YouBike晚間10點後暫停營運ARالأنظار تتجه نحو مواجهة المغرب وفرنسا في ربع نهائي كأس العالمJPトランプ大統領、NATO会議を「大成功」と評価、態度一転に周囲驚くARنتنياهو: لن نسمح لإيران بامتلاك أسلحة نووية وسنبقى في جنوب لبنان طالما لزم الأمرDEDAX stabilisiert sich nach Verlusten; Iran-Konflikt und VW-Sparpläne belastenARالبنك المركزي المصري يثبت أسعار الفائدة الرئيسيةCRYPTO-ENSWIFT Pilot Allows Tokenized Deposits Over WeekendsDESachsens Kultusminister Conrad Clemens wegen illegalen Rennens schuldig gesprochen
Newsgather
GeriChinese Researchers Claim Lead in Parkinson's Stem Cell Therapy
Chinese Researchers Claim Lead in Parkinson's Stem Cell Therapy
Sağlık
SCMP News20.05.2026Sağlık1 dk okumaChina

Chinese Researchers Claim Lead in Parkinson's Stem Cell Therapy

Hızlı Bakış

Chinese company Nuwacell claims its stem cell therapy for Parkinson's disease shows significantly higher efficiency (80-90% conversion) than international competitors (below 25%), citing faster clinical trial timelines.

Yapay zekâ özeti

Neden Önemli?

Parkinson's disease is a movement disorder caused by a lack of dopamine due to the death or dysfunction of specialized neurons. Stem cell therapies are being explored globally to replenish these lost neurons. Nuwacell Biotechnologies, founded by scientists returning from the US, claims to be leading this field.

Yazı boyutu

Chinese researchers claim to be outpacing international competitors in the development of stem cell therapies for Parkinson’s disease, citing higher efficiency and a faster clinical trial timeline.

Parkinson’s is often described as a movement disorder. Its symptoms are caused by the brain’s failure to produce sufficient dopamine, because of the death or dysfunction of the specialised neurons responsible for generating the chemical.

In the search for a cure, researchers around the world are exploring stem cell therapies aimed at replenishing lost dopaminergic neurons – a field in which one Chinese company is claiming to be taking the lead.

Nuwacell Biotechnologies was founded a decade ago in Hefei, Anhui province, by stem cell biologists Yu Junying and Zhang Ying upon their return to China from leading US institutions.

Speaking to the South China Morning Post after an academic exchange conference in Beijing, Yu – the company’s chief scientist – said Nuwacell’s therapy was showing “significantly higher efficiency” than rival international teams from the US and Japan.

“Our cells, once introduced into the body, convert into dopaminergic neurons at a rate of 80 to 90 per cent, whereas published data from other teams are below 25 per cent,” she said.

Açık Sorular

  • What are the specific timelines for Nuwacell's clinical trials?
  • What are the names of the leading US and Japanese institutions developing rival therapies?
  • What are the potential side effects or risks associated with Nuwacell's therapy?
  • Has Nuwacell's therapy been independently verified by other research bodies?

İlgili Konular

Bu haber ilk olarak şurada yayınlandı: SCMP News.

İlgili Haberler

Bu konuda daha fazlaparkinson's disease